Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
ABOUT THIS PAGE
63
PharmaCompass offers a list of Azulene API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Azulene manufacturer or Azulene supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Azulene manufacturer or Azulene supplier.
PharmaCompass also assists you with knowing the Azulene API Price utilized in the formulation of products. Azulene API Price is not always fixed or binding as the Azulene Price is obtained through a variety of data sources. The Azulene Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CL22917 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CL22917, including repackagers and relabelers. The FDA regulates CL22917 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CL22917 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CL22917 supplier is an individual or a company that provides CL22917 active pharmaceutical ingredient (API) or CL22917 finished formulations upon request. The CL22917 suppliers may include CL22917 API manufacturers, exporters, distributors and traders.
click here to find a list of CL22917 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CL22917 DMF (Drug Master File) is a document detailing the whole manufacturing process of CL22917 active pharmaceutical ingredient (API) in detail. Different forms of CL22917 DMFs exist exist since differing nations have different regulations, such as CL22917 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CL22917 DMF submitted to regulatory agencies in the US is known as a USDMF. CL22917 USDMF includes data on CL22917's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CL22917 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CL22917 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CL22917 Drug Master File in Japan (CL22917 JDMF) empowers CL22917 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CL22917 JDMF during the approval evaluation for pharmaceutical products. At the time of CL22917 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CL22917 suppliers with JDMF on PharmaCompass.
CL22917 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CL22917 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CL22917 GMP manufacturer or CL22917 GMP API supplier for your needs.
A CL22917 CoA (Certificate of Analysis) is a formal document that attests to CL22917's compliance with CL22917 specifications and serves as a tool for batch-level quality control.
CL22917 CoA mostly includes findings from lab analyses of a specific batch. For each CL22917 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CL22917 may be tested according to a variety of international standards, such as European Pharmacopoeia (CL22917 EP), CL22917 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CL22917 USP).
